Literature DB >> 18812259

3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: a novel series of mGluR2 positive allosteric modulators.

Lei Zhang1, Bruce N Rogers, Allen J Duplantier, Stanley F McHardy, Ivan Efremov, Helen Berke, Weimin Qian, Andy Q Zhang, Noha Maklad, John Candler, Angela C Doran, John T Lazzaro, Alan H Ganong.   

Abstract

The synthesis and structure-activity relationship (SAR) of a novel series of 3-(imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers, derived from a high throughput screening (HTS), are described. Subsequent optimization led to identification of potent, metabolically stable and orally available mGluR2 positive allosteric modulators (PAMs).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812259     DOI: 10.1016/j.bmcl.2008.09.026

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

Review 1.  Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators.

Authors:  Douglas J Sheffler; Anthony B Pinkerton; Russell Dahl; Athina Markou; Nicholas D P Cosford
Journal:  ACS Chem Neurosci       Date:  2011-04-12       Impact factor: 4.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.